Treating skin cancers with surgery is still the standard of care for most NMSC patients. However, surgery is not without potential downsides, especially for patients with other health issues. Surface radiotherapy, both Electronic Brachytherapy (EBT) and Superficial Radiation Therapy (SRT), is an FDA-approved treatment option and an excellent choice for select NMSC patients. Explore the case study below to see how Dr. Steven Davis has had success treating patients with surface radiation therapy.
Xstrahl Announces Live Demos of Radiant™ AURA and XBeam V2 at AAD 2026
Xstrahl, a global leader in the delivery of superficial and orthovoltage radiation therapy and preclinical radiation research systems, will feature Radiant™ Aura with XBeam treatment planning at the annual meeting of the American Academy of Dermatology (AAD), in Orlando, FL, from March 7-9, 2025 (Booth #2975).
